04.04.2024
To screen patients in preparation for use of medications such as primaquine, MMC's lab will begin offering Glucose-6-phosphate dehydrogenase (G6PD) deficiency screening beginning March 25. For details, read the latest LabMed Report on G6PD.
An archive of LabMed Reports is available here.